Peapack Gladstone Financial Corp Has $34.93 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Peapack Gladstone Financial Corp decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 69,055 shares of the healthcare conglomerate's stock after selling 1,663 shares during the quarter. Peapack Gladstone Financial Corp's holdings in UnitedHealth Group were worth $34,933,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $28,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the 4th quarter worth $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $32,000. Finally, Pillar Financial Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at about $40,000. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent analyst reports. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Mizuho boosted their price objective on UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a research note on Wednesday. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Finally, Truist Financial dropped their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Twenty-one research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $630.35.

Remove Ads

UnitedHealth Group Stock Performance

UNH traded up $10.25 during trading on Wednesday, hitting $563.33. The stock had a trading volume of 4,126,898 shares, compared to its average volume of 4,297,724. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The firm has a market cap of $515.28 billion, a PE ratio of 36.28, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a 50 day simple moving average of $509.40 and a 200-day simple moving average of $541.42. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the firm earned $5.83 EPS. The business's revenue was up 6.8% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.49%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business's stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.